Importantly, we demonstrated that insulin’s ability to suppress plasma BCAAs is impaired in individuals with type 2 diabetes compared with glucose-tolerant individuals with and without obesity in three of our studies. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.